EUVIMEDEUVIMED entdecken
Crossref

Early post-lung transplant cell-free DNA levels are associated with baseline lung allograft dysfunction

Andrea Zajacova, Majd Alkhouri, Goncalo Ferrao, Miray Guney, David Rezac, Kristyna Vyskocilova, Tereza Kotowski, Alzbeta Dutkova, Eliska Dvorackova, Robert Lischke, Libor Fila, David J Ross und 2 weitere

Transplant Immunology · 2025-09 · 92 · 102245

DOI: 10.1016/j.trim.2025.102245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Immunology, 2025-09. Verfasst von Andrea Zajacova und 13 weiteren Autor:innen. Beteiligte Einrichtung: Prague Lung Transplant Program, Department of Pneumology, Second Faculty of Medicine, Charles University, Motol University Hospital, V Uvalu 84, 150 …. Hauptthemen laut MEDLINE: Lung Transplantation, Cell-Free Nucleic Acids, Graft Rejection, Lung. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Natera Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Baseline lung allograft dysfunction (BLAD) is defined as the failure to achieve normal pulmonary function-specifically, forced expiratory volume in 1 s (FEV₁) and forced vital capacity (FVC) values of ≥80 %-within the first year after lung transplantation. It is hypothesised that early subclinical injury, reflected by elevated donor-derived cell-free DNA (dd-cfDNA), both in absolute concentration and percentage (dd-cfDNA%), as well as total cell-free DNA (cfDNA), may be predictive of subsequent BLAD development. METHODS: We included patients who underwent bilateral lung transplantation between May 2021 and September 2023. Blood samples collected between 3 and 9 months post-transplantation were analysed for dd-cfDNA%, dd-cfDNA concentration (copies/mL), and estimated total cfDNA (copies/mL). BLAD was defined by failure to achieve both FEV₁ and FVC ≥80 % of predicted values within the first year. RESULTS: A total of 158 samples from 37 patients were analysed. Ten patients (27 %) met the BLAD criteria. Those with BLAD had significantly higher dd-cfDNA levels (median: 39 cp/mL) compared to non-BLAD patients (26 cp/mL; p = 0.01). Similarly, total cfDNA levels were significantly elevated in the BLAD group (22,809 cp/mL vs. 13,840 cp/mL; p = 0.002). However, dd-cfDNA% did not differ significantly (0.23 % vs. 0.15 %; p = 0.2). CONCLUSION: Elevated absolute dd-cfDNA and total cfDNA levels in the early post-transplant period were associated with BLAD, suggesting that cfDNA may serve as a potential predictive biomarker. These findings support the potential of cfDNA-based biomarkers to enhance early detection of graft dysfunction, warranting validation in larger cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung TransplantationCell-Free Nucleic AcidsGraft RejectionLungPrimary Graft DysfunctionHumansMaleFemaleMiddle AgedAdultAllograftsBiomarkersAgedForced Expiratory VolumeTransplantation, HomologousVital Capacity

Stichwörter der Autor:innen

Baseline lung allograft dysfunctionDonor-derived cell-free DNALung transplantation

Substanzen

Cell-Free Nucleic AcidsBiomarkers

Autor:innen und Institutionen

  • Prague Lung Transplant Program, Department of Pneumology, Second Faculty of Medicine, Charles University, Motol University Hospital, V Uvalu 84, 150 06 Prague, Czechia. Electronic address: andrea.zajacova@fnmotol.cz.
  • Prague Lung Transplant Program, Department of Pneumology, Second Faculty of Medicine, Charles University, Motol University Hospital, V Uvalu 84, 150 06 Prague, Czechia. Electronic address: majd.alkhouri@fnmotol.cz.
  • Second Faculty of Medicine, Charles University, Motol University Hospital, V Uvalu 84, 150 06 Prague, Czechia.
  • 7th Field Hospital of the Army of the Czech Republic, Sokolska 581, 500 05 Hradec Kralove, Czechia. Electronic address: david.rezac@ikem.cz.
  • Prague Lung Transplant Program, Department of Pneumology, Second Faculty of Medicine, Charles University, Motol University Hospital, V Uvalu 84, 150 06 Prague, Czechia. Electronic address: kristyna.vyskocilova@fnmotol.c…
  • Prague Lung Transplant Program, Department of Pneumology, Second Faculty of Medicine, Charles University, Motol University Hospital, V Uvalu 84, 150 06 Prague, Czechia. Electronic address: tereza.kotowski@fnmotol.cz.

Förderung

  • Natera Inc

Zitieren

APA

Zajacova, A., Alkhouri, M., Ferrao, G., Guney, M., Rezac, D., Vyskocilova, K., Kotowski, T., Dutkova, A., Dvorackova, E., Lischke, R., Fila, L., Ross, D. J., Vanaudenaerde, B., & Havlin, J. (2025). Early post-lung transplant cell-free DNA levels are associated with baseline lung allograft dysfunction. Transplant Immunology, 92, 102245. https://doi.org/10.1016/j.trim.2025.102245

Vancouver

Zajacova A, Alkhouri M, Ferrao G, Guney M, Rezac D, Vyskocilova K, et al. Early post-lung transplant cell-free DNA levels are associated with baseline lung allograft dysfunction. Transplant Immunology. 2025;92:102245. doi:10.1016/j.trim.2025.102245

BibTeX
@article{Zajacova2025,
  author = {Zajacova, Andrea and Alkhouri, Majd and Ferrao, Goncalo and Guney, Miray and Rezac, David and Vyskocilova, Kristyna and Kotowski, Tereza and Dutkova, Alzbeta and Dvorackova, Eliska and Lischke, Robert and Fila, Libor and Ross, David J and Vanaudenaerde, Bart and Havlin, Jan},
  title = {Early post-lung transplant cell-free DNA levels are associated with baseline lung allograft dysfunction},
  journal = {Transplant Immunology},
  year = {2025},
  volume = {92},
  pages = {102245},
  doi = {10.1016/j.trim.2025.102245}
}
Kostenlos starten →